Global Circulating Cell-free Tumor DNA Market- Regional Analysis
Among regions, North America is estimated to hold a dominant position in the global Circulating Cell-free Tumor DNA Market over the forecast period. North America holds 45.1% of the market share due to the increasing prevalence of cancer in the region. For instance, according to the American Cancer Society, a scientific cancer journal, in the year 2021, an estimated 1.9 million new cancer cases were diagnosed and 608,570 cancer deaths occurred in the U.S. due to cancer.
Circulating Cell-Free Tumor DNA Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients